GE HealthCare Unveils Sonic DL for 3D, Expanding Deep Learning Innovations in MRI
New 3D imaging capabilities of Sonic DL are designed to enable up to 86%i faster scans and enhanced resolution for...
Pharmaceutical
GE HealthCare Highlights New Solutions Including AI-enabled Innovations to Drive Precision Care at RSNA 2024
Booth (#7330) will showcase new innovations that address the most pressing challenges in healthcare, spanning the care journey across devices,...
Rakovina Therapeutics Announces 2024 Q3 Financial Results and Provides Corporate Update
All dollar amounts reflected in Canadian dollars unless otherwise statedVANCOUVER, British Columbia, Nov. 29, 2024 (GLOBE NEWSWIRE) -- Rakovina Therapeutics...
Cue Biopharma Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
BOSTON, Mass., Nov. 29, 2024 (GLOBE NEWSWIRE) -- Cue Biopharma, Inc. (Nasdaq: CUE), a clinical-stage biopharmaceutical company developing a novel class...
Defence’s Proprietary Accum Technology Ready to License to Companies Developing Antibody Drug Conjugates (ADC)
Vancouver, British Columbia--(Newsfile Corp. - November 29, 2024) - Defence Therapeutics Inc. (CSE: DTC) (OTCQB: DTCFF) (FSE: DTC) ("Defence" or...
Electronic Health Records Market Surges to USD 38.8 Billion by 2030, Propelled by 4.6% CAGR – Verified Market Reports®
The Electronic Health Records (EHR) market is driven by the growing demand for efficient healthcare management systems, increased government initiatives...
AIX Inc. (NASDAQ:AIFU): Reshaping AI Insurance and the Healthcare Industry–A Promising Future Ahead?
HONG KONG, Nov. 29, 2024 /PRNewswire/ -- AIX Inc. (NASDAQ:AIFU) is a leading company focused on insurance agency and claims...
BGM Group Ltd Pioneers Innovation in AI Technology, Fostering Holistic Integration of Healthcare and Insurtech
CHENGDU, China, Nov. 29, 2024 /PRNewswire/ -- BGM Group Ltd. (NASDAQ: BGM) ("the Company" or "BGM"), a leading global pharmaceutical...
TMA Solutions Launched New HealthTech Solutions Driving Innovation in Healthcare
HO CHI MINH CITY, Vietnam, Nov. 29, 2024 /PRNewswire/ -- After several years of intensive investment in R&D, TMA Solutions launched...
Silo Pharma Enters Joint Development Agreement for SP-26 Ketamine Implant Device Targeting Pain Management
Prototype development and feasibility testing underway for optimized subcutaneous delivery SARASOTA, FL, Nov. 29, 2024 (GLOBE NEWSWIRE) -- Silo Pharma,...
TG Therapeutics to Participate in the Evercore HealthCONx Conference
Fireside chat scheduled for Tuesday, December 3, 2024, at 10:00 AM ETNEW YORK, Nov. 29, 2024 (GLOBE NEWSWIRE) -- TG...
Albus Health Device Detects Early Warning Signs of Child Asthma Attacks Up To Five Days Before Onset
Albus Health Device Detects Early Warning Signs of Child Asthma Attacks Up To Five Days Before Onset Research presented at...
HUTCHMED Announces Continued Inclusion of ORPATHYS® (savolitinib) in the National Reimbursement Drug List in China at Current Terms
HONG KONG and SHANGHAI and FLORHAM PARK, N.J., Nov. 28, 2024 (GLOBE NEWSWIRE) -- HUTCHMED (China) Limited (“HUTCHMED”) (Nasdaq/AIM:HCM; HKEX:13)...
Rakovina Therapeutics Announces Private Placement Offering
The Company has received initial commitments totaling over $800,000 from strategic investors in connection with the OfferingVANCOUVER, British Columbia, Nov....
Theralase(R) Release’s 3Q2024 Financial Statements
TORONTO, ON / ACCESSWIRE / November 27, 2024 / Theralase® Technologies Inc. (" Theralase® " or the " Company ")...
Dental Practice Management Market Surges to USD 5.73 Billion by 2030, Propelled by 10.9% CAGR – Verified Market Reports®
The dental practice management market is driven by the increasing prevalence of oral health issues, a growing demand for cosmetic...
ChemAI: AI-Driven Digital Chemistry Pioneer announces Strategic Rebrand and Key Board Appointments
LEEDS, England, Nov. 27, 2024 /PRNewswire/ -- Deepmatter, a leading innovator in digital chemistry, today unveils its rebrand to ChemAI, as part...
Teva Launches Vital Medicines Program in El Salvador for Underserved Communities
NORTHAMPTON, MA / ACCESSWIRE / November 27, 2024 / Teva PharmaceuticalTeva is pleased to announce the launch of a new...
SELLAS Announces Positive Data from Preclinical Studies Indicating ASXL1 Mutations as Predictor of Response to SLS009 in Solid Cancers
- Preselection Method for Cancers Responding to SLS009: High Efficacy of SLS009 Observed in 67% of ASXL1 Mutated Solid Cancers...
PHAXIAM Therapeutics presents an ambitious development strategy to take advantage of the rapidly evolving Phages therapy area
Webinar being held today "Evolving strategic context for phages, Introducing new opportunities" to present PHAXIAM Therapeutics strategyBased on the positive...